Flagship Pioneering CEO Noubar Afeyan at Endpoints JPM24 (Brian Benton Photography)
July 3, 2024 06:00 AM EDTUpdated 06:59 AM
Financing
Startups

Flag­ship ap­pears to boost tar­get of eighth fund by up to $500M

Kyle LaHucik

Senior Reporter

Flag­ship Pi­o­neer­ing, the sprawl­ing life sci­ences in­vestor and start­up in­cu­ba­tor, ap­pears to be seek­ing more cap­i­tal than orig­i­nal­ly planned for its eighth fund.

The Boston …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Roche’s TIG­IT drug tiragolum­ab flunks an­oth­er Phase 3 lung can­cer test

Cir­cle Phar­ma rais­es $54M as part of Se­ries D while macro­cy­cles heat up

In biotech's un­even re­cov­ery, 50 star­tups raised megarounds in first half of 2024

UK trade group slams No­vo, No­var­tis, Pfiz­er and Ot­su­ka for code breach­es

Pfiz­er adds ex-State Street CEO to the board; Two Merus ex­ecs head for the ex­it

Ex­perts want to make it eas­i­er to get RSV vac­cines. Did they make it hard­er in­stead?

A service from the Financial Times